Hamilton Health Sciences Corporation
Clinical trials sponsored by Hamilton Health Sciences Corporation, explained in plain language.
-
Could a poop pill help teens with anorexia?
Disease control Not yet recruitingThis pilot study tests whether fecal microbiota transplant (FMT) – taking capsules made from healthy donor stool – is a feasible and acceptable treatment for 20 teens (ages 12-17) with anorexia nervosa. Participants will take FMT or placebo capsules twice a day, twice a week for …
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Simple antibacterial wash could slash deadly graft infections in vascular surgery
Prevention Not yet recruitingThis study tests whether washing the surgical wound and the new prosthetic graft with a hypochlorous acid solution at the end of surgery can prevent infections. Participants are adults having open surgery to insert a synthetic bypass graft for narrowed or blocked arteries. The st…
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jul 02, 2026 05:00 UTC
-
Massive heart surgery trial aims to slash infection rates
Prevention Not yet recruitingThis study looks at whether adding a second antibiotic (vancomycin) to the standard one (cefazolin) or giving antibiotics for a longer time can prevent serious infections after open-heart surgery. About 38,000 adults having heart surgery will be randomly assigned to one of four a…
Phase: PHASE4 • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
AI and dye join forces to spot leaky gut in IBD patients
Knowledge-focused Not yet recruitingThis study tests a new imaging system that uses a fluorescent dye and artificial intelligence during colonoscopy to measure how leaky the gut lining is in people with inflammatory bowel disease (IBD). It includes 70 adults (60 with IBD and 10 without) at three Canadian hospitals.…
Sponsor: Hamilton Health Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Wearable device could predict deadly surgery complications
Knowledge-focused Not yet recruitingVISION-2 is a large observational study of 20,000 older adults having noncardiac surgery. Participants will wear a continuous vital signs monitor for up to 30 days after surgery. The goal is to find early warning signs of serious complications like heart injury, severe bleeding, …
Sponsor: Hamilton Health Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC